LCAT and hypertriglyceridemia: The in vivo results of the present study show that Tx patients with and without statin therapy had moderate hypertriglyceridemia, hypercholesterolemia, dyslipoproteinemia, and atherogenic lipid and lipoprotein ratios, decreased LCAT mass, and slightly increased hsCRP, but no CETP activity.